MAb114
Sign in to saveAlso known as Ansuvimab
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication used for the treatment of Ebolavirus (Zaire ebolavirus) infection.
~11 min read
Encyclopedic overview
14 sectionsContents
- Chemistry
- Mechanism of action
- Neutralization
- Effector function
- History
- Discovery
- Ansuvimab and mAb100 combination
- Ansuvimab monotherapy
- Development
- Human safety testing
- Ridgeback Biotherapeutics
- Experimental use in the Democratic Republic of Congo
- References
- External links
Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication used for the treatment of Ebolavirus (Zaire ebolavirus) infection.
The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.
Excerpted from Wikipedia’s “MAb114” article, available under the CC BY-SA 4.0 licence.